Teva Recalls Methylphenidate Hydrochloride Extended-Release Tablets Due to Missing Desiccant
Teva Pharmaceuticals is recalling specific bottles of Methylphenidate Hydrochloride Extended-Release tablets because they may be missing the desiccant packet.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible health consequences. The specific defect (missing desiccant) is a quality control issue that may affect drug stability but does not involve acute hazards like contamination or mislabeling of active ingredients.
Plain-English summary
Teva Pharmaceuticals USA is recalling Methylphenidate Hydrochloride Extended-Release tablets, 18 mg, 100-count bottles. The recall is limited to Lot #1332796 A with an expiration date of 11/2020. The product is a prescription-only medication (CII) distributed nationwide in the United States.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the product bottles may be absent of the desiccant packet. The desiccant is included to maintain the stability and quality of the medication.
Consumers and healthcare providers with this specific lot of medication should stop using it and contact their pharmacist or Teva Pharmaceuticals for further instructions on how to return or dispose of the product.
The recalled product
- Product
- METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)
- Brand
- METHYLPHENIDATE HYDROCHLORIDE
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 1332796 A
- Exp 11/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Teva Pharmaceuticals USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · METHYLPHENIDATE HYDROCHLORIDE
- HighMethylphenidate Hydrochloride Extended-Release Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2024-07-10
- HighMethylphenidate Hydrochloride Tablets Recalled Due to Metal Contamination
FDA (Drugs) · 2023-08-02
- ModerateMethylphenidate Hydrochloride Chewable Tablets Recalled for Failed Specifications
FDA (Drugs) · 2022-03-02
- ModerateTeva Recalls Methylphenidate Hydrochloride Extended-Release Tablets Due to Missing Desiccant
FDA (Drugs) · 2020-02-19
- ModerateOsmotica Recalls Subpotent Methylphenidate Hydrochloride Extended-Release Tablets
FDA (Drugs) · 2018-03-14
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · quality control
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateDuoGlide Short-Term Dialysis Catheter recall due to deficient manufacturing
FDA (Devices) · 2026-07-08
- ModeratedirectCHECK whole blood control labeled with incorrect performance range
FDA (Devices) · 2026-06-24
- HighAmyloid plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11